#8472. Response to letter to the editor “the impact of bisphosphonates on mortality and cardiovascular risk among osteoporosis patients after cardiovascular disease”

September 2026publication date
Proposal available till 30-05-2025
4 total number of authors per manuscript3000 $

The title of the journal is available only for the authors who have already paid for
Journal’s subject area:
Medicine (all);
Places in the authors’ list:
place 1place 2place 3place 4
FreeFreeFreeFree
900 $800 $700 $600 $
Contract №8472.1 Contract №8472.2 Contract №8472.3 Contract №8472.4
1 place - free (for sale)
2 place - free (for sale)
3 place - free (for sale)
4 place - free (for sale)

Abstract:
We study the effects of bisphosphonate (BP) therapy on the survival rate of osteoporosis patients after acute coronary syndrome (ACS). The review of hospitalization cases revealed a considerable risk of atrial fibrillation associated with bisphosphonate use. However, complience with the BP therapy brings positive health outcomes, such as lower risk of
fracture.
Keywords:
osteoporosis; bisphosphonate treatment; survival rate; cardiovascular risk; drug-induced atrial fibrillation; hospitalization

Contacts :
0